City
Epaper

Google to lift ban on FDA-approved stem cell therapy ads

By IANS | Updated: May 11, 2022 19:55 IST

San Francisco, May 11 Tech giant Google is set to remove the ban imposed on FDA-approved stem cell ...

Open in App

San Francisco, May 11 Tech giant Google is set to remove the ban imposed on FDA-approved stem cell therapy ads from July.

The move, which is to update its healthcare and medicine policy, will be effective from July 11.

"The update will permit the promotion of FDA-licensed or approved cell or gene therapies in the US by entities that hold the relevant FDA-issued licence or approval to market that product.

"We will begin rolling out the policy update on July 11, 2022 with full enforcement ramping up over approximately 4 weeks," the company said in a statement.

However, companies that do not have an FDA-issued licence or approval will still be unable to promote cell therapies and gene therapies on Google Ads.

In 2019, Google had announced a policy to prohibit advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy, and gene therapy owing to "rise in bad actors".

"Rise in bad actors attempting to take advantage of individuals by offering untested, deceptive treatments," the company had said.

"Oftentimes, these treatments can lead to dangerous health outcomes and we feel they have no place on our platforms," it added.

The policy prohibited ads selling treatments that have no established biomedical or scientific basis. It also included treatments that are rooted in basic scientific findings and preliminary clinical experience, but currently have insufficient formal clinical testing to justify widespread clinical use.

In the 2022 update, Google also clarified "policy language to allow ads for cell or gene therapies, globally, that are exclusively educational or informational in nature, regardless of regulatory approval status."

Stem cell therapy is a broad term for medical treatments that use stem cells, which can develop into any cell type. There are some evidence-based applications for the cells, like to treat some cancers, and there are around two dozen FDA-approved cell-and gene-therapy products.

But most uses for stem cells are unproven, experimental, and can be dangerous.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: usgoogleSan FranciscoSan francisco bayWord on macWho dgMicrosoft incUs google & youtubeSk duaJose d'sa
Open in App

Related Stories

FootballEnglish Premier League 2025-26 Google Doodle: Search Engine Giant Celebrates Start of Season With Football-Themed

InternationalHurricane Erin Enters Into Category 2 Storm With Maximum Winds of 100 mph, Heavy Rainfall Over Caribbean Islands Likely

NationalAir India to Suspend Direct Delhi–Washington Services from September 1, Offers Alternate Routes

MumbaiCyber Fraud in Mumbai: Elderly Woman Loses Rs 98,202 After Calling Fake Customer Care Number Found on Internet

NationalBITS Pilani Placement 2025: Over 80% Students Placed, Average Salary Rises to Rs 19.4 Lakh

Technology Realted Stories

TechnologyOdisha CM Mohan Majhi launches ‘BharatNetra’ initiative

TechnologySEMICON India 2025 to be South Asia’s largest platform for semiconductor, electronics innovation: MeitY Secretary

TechnologyGovt focused on critical communications system to counter climate disasters: TRAI Chairman

TechnologyIndia showcases leadership in quality, safety benchmarks for herbal medicines

TechnologyUrea production witnesses 35 pc growth over past decade, DAP sees 44 pc rise: Govt